|
Uterine Artery Embolization
for Symptomatic Leiomyomata
Jay Goldberg, MD, MSCP
In the appropriate patients,
this safe, nonsurgical option
offers an array of medical and
economical advantages.
BONUS Coding Box on page 49
Botulinum Toxin in the
Treatment of Neurogenic
and Idiopathic Urinary
Incontinence
Travis L. Bullock, MD;
Carl G. Klutke, MD;
John J. Klutke, MD
Off-label use has yielded promising
clinical outcomes, but will larger
studies deem BTX a valid
therapeutic alternative?
The Noncompliant Patient
Bruce A. Berger, PhD
Stepping into the patient’s shoes
may be the key to tackling this
detrimental dilemma.
The United States Preventive Services Task Force:
Putting Recommendations
Into Practice
Janelle Guirguis-Blake, MD;
Barbara P. Yawn MD, MSc
Amidst a climate of contrasting views, these “gold standards” clear the way
for proper clinical implementation.
back
to top
Departments
Editorial
The Compliance Conundrum
Ronald T. Burkman, MD
In the Pipeline
New Products
Case Report
Uterine Artery Embolization
Complicated by Nontarget
Labial Embolization
Jay Goldberg, MD, MSCP;
Maria Mella, BS
My Most Memorable
Moment
Winter Headaches
Prospero A. Flores, MD
Author Guidelines
CME Test
Patient Handout
What You Should Know About
Uterine Fibroids
Folleto Informativo Para La Paciente
Lo que Usted debe Saber sobre los Fibromas Uterinos
What Your Patients
are Reading
Classified Advertisements
back
to top |
